| Line Item | 2023-03-31 | Y/Y |
|---|---|---|
| Revenue | $911K | +129.5% |
| Cost of Revenue | $469K | +131.0% |
| Gross Profit | $442K | +127.8% |
| R&D Expense | $3.5M | +48.5% |
| SG&A Expense | $8.6M | -35.7% |
| Operating Income | -$11.6M | +25.0% |
| Interest Expense | $5K | +0.0% |
| Pre-tax Income | -$11.5M | +23.4% |
| Income Tax | $0 |
| Line Item | 2023-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.2M | -69.4% |
| Short-term Investments | $154K | — |
| Accounts Receivable | $107K | -14.4% |
| Inventory | $2.7M | -25.3% |
| Current Assets | $6.5M | -57.2% |
| Total Assets | $17.2M | -36.0% |
| Current Liabilities | $1.9M | -22.2% |
| Line Item | 2023-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.0M | +5.6% |
| Capital Expenditures | $310K | +49.8% |
| Investing Cash Flow | -$235K | +68.3% |
| Financing Cash Flow | $100K | -97.6% |
| Free Cash Flow | -$7.4M | +4.1% |
| — |
| Net Income | -$11.5M | +23.4% |
| Long-term Debt |
| $141K |
| -2.1% |
| Total Liabilities | $2.3M | -22.9% |
| Stockholders' Equity | $14.9M | -37.6% |